
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you open and fund a new account within 30 days
- Access to a financial planner
BIO-Key International is a security & protection services business based in the US. BIO-Key International shares (BKYI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.79 – a decrease of 5.28% over the previous week. BIO-Key International employs 41 staff and has a trailing 12-month revenue of around $6.9 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Latest market close | $0.79 |
---|---|
52-week range | $0.52 - $3.22 |
50-day moving average | $0.86 |
200-day moving average | $1.10 |
Wall St. target price | $2.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-2.09 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.789 from 2025-05-23
1 week (2025-05-16) | -5.28% |
---|---|
1 month (2025-04-25) | -0.68% |
3 months (2025-02-25) | -21.10% |
6 months (2024-11-25) | -14.24% |
1 year (2024-05-24) | -58.47% |
---|---|
2 years (2023-05-25) | -94.52% |
3 years (2022-05-25) | 32.7582 |
5 years (2020-05-22) | 105.12 |
Revenue TTM | $6.9 million |
---|---|
Gross profit TTM | $5.6 million |
Return on assets TTM | -38.18% |
Return on equity TTM | -177.88% |
Profit margin | -62.06% |
Book value | $1.02 |
Market Capitalization | $4.8 million |
TTM: trailing 12 months
We're not expecting BIO-Key International to pay a dividend over the next 12 months.
BIO-Key International's shares were split on a 1:18 basis on 20 December 2023 . So if you had owned 18 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BIO-Key International shares – just the quantity. However, indirectly, the new 1700% higher share price could have impacted the market appetite for BIO-Key International shares which in turn could have impacted BIO-Key International's share price.
Over the last 12 months, BIO-Key International's shares have ranged in value from as little as $0.5187 up to $3.2199. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BIO-Key International's is 0.244. This would suggest that BIO-Key International's shares are less volatile than average (for this exchange).
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, services and cloud host, as well as windows device authentication through IAM platform. The company's solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, the company offers finger scanners for enterprise and consumer markets under SideSwipe, PIV Pro, EcoID II, and SidePass brand names; and fingerprint readers. Additionally, it provides identity and access management, user multi-factor authentication, and privilege entitlement and access control solutions.
Learn how and where to buy Fannie Mae (FNMA) stock, view trends and see what may be ahead for share holders.
See how and where to buy Freddie Mac (FMCC) stock, view past price performance and learn what’s ahead for shareholders.
Direct indexing lets you replicate the performance of a specific index with potentially more tax efficiency. Learn how to get started here.
A deep dive into the highlights and limitations of Frec.
Explore the best bonuses for opening a new brokerage account.
It can help reduce taxes owed, but it’s not for beginners.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
The ins and outs of bundling stocks with this accessible investing option.
A deep dive into the highlights and limitations of Robinhood.